In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Spinal Concepts raises $9.3mm

Executive Summary

Spinal Concepts (founded in 1996; spinal implants) raised $9.3 in a Series D financing led by affiliates of Donaldson, Lufkin & Jenrette, along with Vector Fund Management, Onset Ventures, and Magic Venture Capital. The company has raised $21mm to date.
Deal Industry
  • Medical Devices
    • Implantable Devices
  • Biotechnology
    • Gene Therapy, Cell Therapy
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies